Your browser doesn't support javascript.
loading
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
Al-Ani, Mena; Elemam, Noha Mousaad; Hundt, Jennifer Elisabeth; Maghazachi, Azzam A.
Afiliação
  • Al-Ani M; Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Elemam NM; Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Hundt JE; Lübeck Institute for Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Maghazachi AA; Department of Clinical Sciences, College of Medicine and the Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
Infect Drug Resist ; 13: 3243-3254, 2020.
Article em En | MEDLINE | ID: mdl-33061471
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Drug Resist Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Drug Resist Ano de publicação: 2020 Tipo de documento: Article